Pharmacy Times: How AI, machine learning can benefit pharmaceutical development, research – University of Cincinnati

Pharmacy Times highlighted a presentation from the University of Cincinnati’s Shawn Xiong discussing the potential for artificial intelligence (AI) and machine learning to bolster pharmaceutical development and research.
Xiong, PhD, assistant professor at UC’s James L. Winkle College of Pharmacy, presented the American Pharmacists Association (APhA)-Academy of Pharmaceutical Research and Science Keynote at the 2024 APhA Meeting and Exposition March 22.
In the pharmaceutical industry, Xiong said the top three use cases for AI are predictive maintenance, quality inspection and assurance and manufacturing process optimization. In clinical practice, Xiong said early detection and personalized treatment are particularly exciting areas of potential.
“This is not only about identifying the disease itself,” Xiong said. “It’s also about providing insights into the unique situations of the patient so that we can make personalized treatments for the patient, especially considering the concept of patient-centered care.”
While the potential is encouraging, Xiong noted there are still limitations and concerns, including nuances of medical language and privacy and security concerns with patient data. As these issues are addressed, however, Xiong said AI and machine learning could significantly improve the future of pharmacy.
“AI and machine learning can help automate the medication filling process, improving accuracy and also saving time,” Xiong said. “The AI can help check and double-check errors in the medication orders, and they can help us identify errors and reduce errors so that patients are getting what they need and how they need it.”

Read the Pharmacy Times article.

Featured image courtesy of Adobe Stock.

April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.

August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.

April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.

University of Cincinnati
2600 Clifton Ave.
Cincinnati, OH 45220
513-556-0000
University of Cincinnati | 2600 Clifton Ave. | Cincinnati, OH 45221 | ph: 513-556-6000
Alerts | Clery and HEOA Notice | Notice of Non-Discrimination | eAccessibility Concern | Privacy Statement | Free Speech | Copyright Information
© 2024 University of Cincinnati
University of Cincinnati
2600 Clifton Ave.
Cincinnati, OH 45220
513-556-0000
© 2024 University of Cincinnati

source

Leave a Reply

The Future Is A.I. !
To top
en_USEnglish